1. Academic Validation
  2. A practical approach to the management of cerebral amyloid angiopathy

A practical approach to the management of cerebral amyloid angiopathy

  • Int J Stroke. 2021 Jun;16(4):356-369. doi: 10.1177/1747493020974464.
Mariel G Kozberg 1 2 3 Valentina Perosa 1 2 3 4 M Edip Gurol 2 3 Susanne J van Veluw 1 2 3
Affiliations

Affiliations

  • 1 MassGeneral Institute for Neurodegenerative Disease, 2348Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
  • 2 Department of Neurology, 2348Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • 3 Hemorrhagic Stroke Research Program, J. Philip Kistler Stroke Research Center, Department of Neurology, 2348Massachusetts General Hospital, Harvard Medical School, Boston, MA,USA.
  • 4 Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.
Abstract

Cerebral amyloid angiopathy is a common small vessel disease in the elderly involving vascular Amyloid-β deposition. Cerebral amyloid angiopathy is one of the leading causes of intracerebral hemorrhage and a significant contributor to age-related cognitive decline. The awareness of a diagnosis of cerebral amyloid angiopathy is important in clinical practice as it impacts decisions to use lifelong anticoagulation or nonpharmacological alternatives to anticoagulation such as left atrial appendage closure in patients who have concurrent atrial fibrillation, another common condition in older adults. This review summarizes the latest literature regarding the management of patients with sporadic cerebral amyloid angiopathy, including diagnostic criteria, imaging biomarkers for cerebral amyloid angiopathy severity, and management strategies to decrease intracerebral hemorrhage risk. In a minority of patients, the presence of cerebral amyloid angiopathy triggers an autoimmune inflammatory reaction, referred to as cerebral amyloid angiopathy-related inflammation, which is often responsive to immunosuppressive treatment in the acute phase. Diagnosis and management of cerebral amyloid angiopathy-related inflammation will be presented separately. While there are currently no effective therapeutics available to cure or halt the progression of cerebral amyloid angiopathy, we discuss emerging avenues for potential future interventions.

Keywords

Cerebral amyloid angiopathy; cortical superficial siderosis; intracerebral hemorrhage; microbleeds; microinfarcts; small vessel disease.

Figures